Contract-Resource-Outsourcing-IndustryNews

11. Meissner Delivers Its One-Touch Portfolio For Single-Use Fluid Management Solutions 2/23/2010
    Meissner Filtration Products delivers its One-Touch single-use systems (SUS) portfolio to provide optimized mobile fluid management solutions for pharmaceutical and biomanufacturing applications.
12. PPD's Global Central Lab in Singapore Earns CAP Accreditation 2/11/2010
    PPD, Inc. recently announced its global central lab operations in Singapore has earned accreditation by the College of American Pathologists (CAP), validating its ability to deliver high-quality, reliable data that meet the highest standard of excellence in enhancing patient safety and speeding drug development.
13. clinicalprojects International GmbH Announces Further Growth Into New Therapeutic And Geographic Areas 2/2/2010
    clinicalprojects international GmbH (CPI), an independent contract research organization, announced today that the company is continuing its growth into new therapeutic areas for the development of (bio)pharmaceuticals and medical devices.
14. FDA Approves ZEGERID OTC For Over-The-Counter Treatment Of Frequent Heartburn 12/3/2009
    Merck & Co., Inc. recently announced that the U.S. Food and Drug Administration (FDA) has approved ZEGERID OTC (omeprazole 20 mg/sodium bicarbonate 1100 mg capsules), for over-the-counter treatment of frequent heartburn.
15. Integra Foundation Awards Grant To Support Pediatric Neurosurgery Resident Education 12/3/2009
    The Integra Foundation, the philanthropic arm of Integra LifeSciences Corporation (Nasdaq:IART), announced today that it has awarded a $12,000 grant to the American Association of Neurological Surgeons (AANS)/Congress of Neurological Surgeons (CNS) Joint Section for Pediatric Neurosurgery, in support of the section's annual meeting, which is taking place at the Boston Marriott Copley Place in Boston, Massachusetts, December 1-4, 2009.
16. PPD To Acquire BioDuro 11/19/2009
    PPD, Inc. (Nasdaq: PPDI) today announced it has signed an agreement to acquire BioDuro LLC, a drug discovery outsourcing company that provides a broad range of integrated services to biopharmaceutical companies. The acquisition will expand PPD's drug development capabilities in China.
17. TRIN Pharma Starts Phase I Clinical Trial Of TRIN 2755 In Solid Tumors 11/12/2009

    TRIN Pharma GmbH, specializing in the development of small molecule drugs for tumor treatment, announced today that BfArM, the German regulatory authority, has approved the start of a Phase I clinical trial of TRIN 2755 in solid tumors.

18. World's largest Malaria Vaccine Trial Now Underway In Seven African Countries 11/5/2009
    A pivotal efficacy trial of RTS,S, the world’s most clinically advanced malaria vaccine candidate, is now underway in seven African countries: Burkina Faso, Gabon, Ghana, Kenya, Malawi, Mozambique and Tanzania.
19. Transparent Inc. To Introduce Cell-Able, A Unique Human Hepatocyte Array, To U.S. Market At ISSX Meeting 10/20/2009
    Transparent, Inc., a bio-venture business headquartered here, announced recently that it will be introducing Cell-able, a human hepatocyte array kit that has the potential to reduce drug development costs and time-to-market for pharmaceutical companies, at its exhibit at the annual meeting of the International Society for the Study of Xenobiotics in Baltimore, Maryland, October 18-22.
20. ACTEMRA Inhibits Progression Of Joint Destruction In RA Patients By Over 80% Compared To Methotrexate Alone 10/20/2009
    Two-year data from the LITHE study, being presented at the American College of Rheumatology, show that, with long-term use, patients with rheumatoid arthritis treated with ACTEMRA (tocilizumab, known as RoACTEMRA within the EU) plus methotrexate (MTX) suffered 81% less damage to their joints compared to those treated with MTX, the current standard therapy, alone1. For patients, this means that their joint damage is significantly reduced, and that they can therefore continue to enjoy their lives without the evolving disability usually associated with the disease.